合并与不合并2型糖尿病的COVID-19住院患者炎症与死亡率的关系
在哥伦比亚大学欧文医学中心开展538例COVID-19住院患者的病例对照(死亡-存活)研究,按糖尿病状态分层,检测8种细胞因子和趋化因子。多因素logistic回归显示IL-6、IL-8和IP10升高与死亡率显著相关,且在各糖尿病分层中关联一致。
要点
- IL-6每升高一个对数单位,死亡风险aOR为1.74(95%CI 1.48-2.06)。
- IL-8的aOR为1.75(95%CI 1.41-2.19),IP10的aOR为1.36(95%CI 1.24-1.51)。
- 上述炎症标志物与死亡率的关联在各糖尿病分层中一致。
核心结论
- COVID-19患者死亡率与血清先天炎症细胞因子IL-6及趋化因子IL-8、IP10升高相关,该关联在糖尿病各分层中一致。
研究设计与样本
- 哥伦比亚大学欧文医学中心开展的病例对照(死亡-存活)研究,纳入538例COVID-19住院患者并按2型糖尿病状态分层。
- 采用免疫分析定量血清中8种细胞因子和趋化因子,包括IFN-α2、IFN-γ、IL-1α、IL-1β、IL-6、IL-8/CXCL8、IP10/CXCL10和TNF-α。
- 采用logistic回归模型分析对数转换的炎症标志物(或其主成分)与死亡率的关系。
主要发现
- 多因素logistic回归中,IL-6升高与死亡率显著相关(aOR 1.74,95%CI 1.48-2.06)。
- IL-8升高与死亡率显著相关(aOR 1.75,95%CI 1.41-2.19)。
- IP10升高与死亡率显著相关(aOR 1.36,95%CI 1.24-1.51)。
- 第二主成分(载荷反映上述3种标志物的相似性)与死亡率显著相关(aOR 1.88,95%CI 1.54-2.31)。
- 上述相同的炎症标志物与死亡率的显著正关联在各糖尿病分层内均观察到。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: COVID-19 mortality is increased in patients with diabetes. A common hypothesis is that the relationship of inflammation with COVID-19 mortality differs by diabetes status. OBJECTIVE: The aim of this study was to determine the relationship of inflammation with mortality in COVID-19 hospitalized patients and to assess if the relationship differs by strata of type 2 diabetes status. METHODS: A case-control (died-survived) study of 538 COVID-19 hospitalized patients, stratified by diabetes status, was conducted at Columbia University Irving Medical Center. We quantified the levels of 8 cytokines and chemokines in serum, including interferon (IFN)-α2, IFN-γ, interleukin (IL)-1α, IL-1β, IL-6, IL-8/CXCL8, IFNγ-induced protein 10 (IP10)/CXCL10 and tumor necrosis factor α (TNF-α) using immunoassays. Logistic regression models were used to model the relationships of log-transformed inflammatory markers (or their principal components) and mortality. RESULTS: In multiple logistic regression models, higher serum levels of IL-6 (adjusted odds ratio [aOR]:1.74, 95% CI [1.48, 2.06]), IL-8 (aOR: 1.75 [1.41, 2.19]) and IP10 (aOR: 1.36 [1.24, 1.51]), were significantly associated with mortality. This association was also seen in second principal component with loadings reflecting similarities among these 3 markers (aOR: 1.88 [1.54-2.31]). Significant positive association of these same inflammatory markers with mortality was also observed within each strata of diabetes. CONCLUSION: We show that mortality in COVID-19 patients is associated with elevated serum levels of innate inflammatory cytokine IL-6 and inflammatory chemokines IL-8 and IP10. This relationship is consistent across strata of diabetes, suggesting interventions targeting these innate immune pathways could potentially also benefit patients with diabetes.
引用
- Guo J, Lin WW, Zucker JE, et al. Inflammation and Mortality in COVID-19 Hospitalized Patients With and Without Type 2 Diabetes. J Clin Endocrinol Metab. 2022. PMID: 34999821. doi:10.1210/clinem/dgac003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。